Payden & Rygel’s Oracle ORCL Stock Holding History

Payden & Rygel’s Portfolio ORCL Stock Details ORCL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$572K	Sell	3,890 -3,200	-45%	-$520K	0.04%	87
2025 Q4	$1.38M	Sell	7,090 -81,300	-92%	-$19.4M	0.1%	76
2025 Q3	$24.9M	Sell	88,390 -3,900	-4%	-$993K	2.06%	11
2025 Q2	$20.2M	Buy	92,290 +24,500	+36%	+$3.96M	1.67%	23
2025 Q1	$9.48M	Sell	67,790 -17,900	-21%	-$2.91M	0.81%	62
2024 Q4	$14.3M	Buy	85,690 +20,400	+31%	+$3.62M	1.23%	39
2024 Q3	$11.1M	Buy	65,290 +300	+0.5%	+$43.5K	0.86%	59
2024 Q2	$9.18M	Sell	64,990 -81,800	-56%	-$10.2M	0.74%	63
2024 Q1	$18.4M	Buy	146,790 +500	+0.3%	+$57.2K	0.87%	35
2023 Q4	$15.4M	Hold	146,290	–	–	1.07%	47
2023 Q3	$15.5M	Buy	146,290 +1,530	+1%	+$177K	1.06%	33
2023 Q2	$17.2M	Sell	144,760 -62,900	-30%	-$6.5M	1.22%	31
2023 Q1	$19.3M	Buy	207,660 +160,960	+345%	+$14.1M	1.14%	39
2022 Q4	$3.82M	Hold	46,700	–	–	0.2%	78
2022 Q3	$2.85M	Buy	46,700 +22,300	+91%	+$1.63M	0.17%	79
2022 Q2	$1.71M	Buy	24,400 +14,300	+142%	+$1.05M	0.1%	83
2022 Q1	$836K	Buy	10,100 +3,000	+42%	+$243K	0.04%	97
2021 Q4	$619K	Buy	+7,100	New	+$667K	0.03%	101
2021 Q1	–	Sell	-1,500	Closed	-$97K	–	146
2020 Q4	$97K	Hold	1,500	–	–	0.01%	116
2020 Q3	$90K	Hold	1,500	–	–	0.01%	106
2020 Q2	$83K	Hold	1,500	–	–	0.01%	97
2020 Q1	$73K	Hold	1,500	–	–	0.01%	99
2019 Q4	$79K	Hold	1,500	–	–	﹤0.01%	107
2019 Q3	$83K	Hold	1,500	–	–	0.01%	101
2019 Q2	$85K	Hold	1,500	–	–	0.01%	99
2019 Q1	$81K	Sell	1,500 -5,400	-78%	-$275K	0.01%	101
2018 Q4	$312K	Hold	6,900	–	–	0.03%	78
2018 Q3	$356K	Hold	6,900	–	–	0.03%	74
2018 Q2	$304K	Buy	6,900 +5,400	+360%	+$249K	0.02%	77
2018 Q1	$69K	Hold	1,500	–	–	0.01%	103
2017 Q4	$71K	Hold	1,500	–	–	0.01%	101
2017 Q3	$73K	Hold	1,500	–	–	0.01%	101
2017 Q2	$75K	Hold	1,500	–	–	0.01%	93
2017 Q1	$67K	Hold	1,500	–	–	0.01%	96
2016 Q4	$58K	Hold	1,500	–	–	0.01%	98
2016 Q3	$59K	Hold	1,500	–	–	0.01%	93
2016 Q2	$61K	Hold	1,500	–	–	0.01%	94
2016 Q1	$61K	Sell	1,500 -1,000	-40%	-$37K	0.01%	97
2015 Q4	$91K	Buy	2,500 +1,000	+67%	+$38.2K	0.01%	93
2015 Q3	$54K	Hold	1,500	–	–	0.01%	107
2015 Q2	$60K	Hold	1,500	–	–	0.01%	111
2015 Q1	$65K	Hold	1,500	–	–	0.01%	116
2014 Q4	$67K	Hold	1,500	–	–	0.01%	108
2014 Q3	$57K	Hold	1,500	–	–	0.01%	117
2014 Q2	$61K	Hold	1,500	–	–	0.02%	119
2014 Q1	$61K	Hold	1,500	–	–	0.02%	110
2013 Q4	$57K	Hold	1,500	–	–	0.02%	149
2013 Q3	$50K	Hold	1,500	–	–	0.02%	135
2013 Q2	$46K	Buy	+1,500	New	+$49.8K	0.02%	133

Other funds holding ORCL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Payden & Rygel's ORCL Position: Q1 2026 in Review

Payden & Rygel reduced its Oracle (ORCL) stake by 45% in Q1 2026, selling an estimated $520K and leaving 3,890 shares worth $572K. The position accounts for 0.04% of the portfolio, ranked #87.

Payden & Rygel first reported a position in ORCL in Q2 2013 and has held it in 49 quarters since. The position peaked at $24.9M in Q3 2025. 3,473 funds tracked by Wall St. Rank hold ORCL as of Q1 2026.

Payden & Rygel held 3,890 shares of Oracle worth $572K as of Q1 2026.
Payden & Rygel sold 3,200 Oracle shares in Q1 2026, an estimated $520K.
Oracle made up 0.04% of Payden & Rygel's portfolio in Q1 2026, its #87 holding.
Payden & Rygel first reported a position in Oracle in Q2 2013 and has held it in 49 quarters since.
Payden & Rygel's Oracle position peaked at $24.9M in Q3 2025.
3,473 funds tracked by Wall St. Rank held Oracle as of Q1 2026.

Based on Payden & Rygel's 13F filing for Q1 2026, filed 12 May 2026.